XSITE 2013 →
Boston Angel Investors →
Professor of Molecular Biology, Rockefeller University
Chair of the Dept. of Chemical Physiology, The Scripps Research Institute
Managing Director, Project 11
Senior Managing Partner, Aisling Capital Fund
Partner, Nixon Peabody LLP
General Partner, Flybridge Capital Partners
CEO and Co-Founder, Sage Bionetworks
Andrew Hurd, CEO of Epocrates. Image courtesy of Epocrates.
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.